Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Study of Avapritinib Efficacy and Safety of Metastatic or Unresectable Gastrointestinal Stromal Tumors

NCT05464875 is registered in ClinicalTrials.gov with Xinhua Zhang, MD as lead sponsor.

NCT NCT05464875
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05464875 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Study of Avapritinib Efficacy and Safety of Metastatic or Unresectable Gastrointestinal Stromal Tumors
Lead sponsor
Xinhua Zhang, MD
Phase
Observational
Overall status
Recruiting
Start date
July 9, 2022
Completion date
December 31, 2025
Enrollment
74 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastrointestinal stromal tumors, recurrent metastatic malignant neoplasm, unresectable solid tumor